Early diagnosis of oesophageal cancer

Squamous cell carcinoma and adenocarcinoma of the oesophagus are cancers that develop from distinct epithelial sub-types; however, they are both related to chronic inflammation of differing aetiologies. Inflammation leads to somatically inherited genetic mutations altering control of the cell cycle, DNA replication and apoptosis, which together result in autonomous and uncontrolled proliferation. These cancers have often metastasised to lymph nodes and distant organs before symptomatic presentation and therefore carry a poor prognosis. It is therefore vital to diagnose oesophageal cancer at an early stage, before the development of symptoms, when treatment can dramatically improve prognosis. Understanding the pathogenesis of these cancers is vital to guide early diagnostic strategies.

[1]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[2]  T. Kawano,et al.  Detection and classification of early squamous cell esophageal cancer. , 1997, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[3]  P. Taylor,et al.  Studies of esophageal balloon cytology in Linxian, China. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[4]  P R Taylor,et al.  Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in linxian, china , 1998, Cancer.

[5]  R. Sandler,et al.  Is there publication bias in the reporting of cancer risk in Barrett's esophagus? , 2000, Gastroenterology.

[6]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[7]  A. Nakao,et al.  Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  G. Lapertosa,et al.  Risk factors for Barrett's esophagus: A case‐control study , 2002, International journal of cancer.

[9]  A. Nakao,et al.  Molecular detection of circulating esophageal squamous cell cancer cells in the peripheral blood. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[10]  P. Groeneveld,et al.  Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[11]  Paul Fockens,et al.  A randomized crossover study comparing light-induced fluorescence endoscopy with standard videoendoscopy for the detection of early neoplasia in Barrett's esophagus. , 2005, Gastrointestinal endoscopy.

[12]  Paul Fockens,et al.  Endoscopic video-autofluorescence imaging followed by narrow band imaging for detecting early neoplasia in Barrett's esophagus. , 2006, Gastrointestinal endoscopy.

[13]  T Fearn,et al.  Elastic scattering spectroscopy accurately detects high grade dysplasia and cancer in Barrett’s oesophagus , 2005, Gut.

[14]  Kenneth K Wang,et al.  Endoscopic Trimodal Imaging Improves the Detection of High-Grade Dysplasia (HGD) and Early Cancer (EC) in Barrett’s Esophagus: An International Multicenter Study , 2007 .

[15]  A. Ensari,et al.  The usefulness of chromoendoscopy with methylene blue in Barrett’s metaplasia and early esophageal carcinoma , 2008, Surgical Endoscopy.

[16]  L. Lovat,et al.  Cyclin A Immunocytology as a Risk Stratification Tool for Barrett's Esophagus Surveillance , 2006, Clinical Cancer Research.

[17]  C. Abnet,et al.  Promoter Methylation in Cytology Specimens as an Early Detection Marker for Esophageal Squamous Dysplasia and Early Esophageal Squamous Cell Carcinoma , 2008, Cancer Prevention Research.

[18]  M. Vieth,et al.  Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett’s oesophagus , 2008, Gut.

[19]  L. Murray,et al.  The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis. , 2008, American journal of epidemiology.

[20]  P. Testoni,et al.  Optical coherence tomography in detection of dysplasia and cancer of the gastrointestinal tract and bilio-pancreatic ductal system. , 2008, World journal of gastroenterology.

[21]  Michael B Wallace,et al.  Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett's Esophagus. , 2008, Gastroenterology.

[22]  Kenneth K Wang,et al.  Gains and Amplifications of c-myc, EGFR, and 20.q13 Loci in the No Dysplasia–Dysplasia–Adenocarcinoma Sequence of Barrett's Esophagus , 2008, Cancer Epidemiology Biomarkers & Prevention.

[23]  Tetsuo Ito,et al.  Three-Tiered Risk Stratification Model to Predict Progression in Barrett's Esophagus Using Epigenetic and Clinical Features , 2008, PloS one.

[24]  Kamran Ayub,et al.  Cell Proliferation, Cell Cycle Abnormalities, and Cancer Outcome in Patients with Barrett's Esophagus: A Long-term Prospective Study , 2008, Clinical Cancer Research.

[25]  M. Coleman,et al.  Continuing Rapid Increase in Esophageal Adenocarcinoma in England and Wales , 2008, The American Journal of Gastroenterology.

[26]  X. Fang,et al.  An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis. , 2008, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[27]  S. Sabatino,et al.  Trends in esophageal cancer incidence by histology, United States, 1998–2003 , 2008, International journal of cancer.

[28]  M. Rugge,et al.  Prediction of Lymph Node Status in Superficial Esophageal Carcinoma , 2008, Annals of Surgical Oncology.

[29]  J. Luketich,et al.  Use of novel autoantibody and cancer-related protein arrays for the detection of esophageal adenocarcinoma in serum. , 2008, The Journal of thoracic and cardiovascular surgery.

[30]  J. Hornick,et al.  Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett's esophagus: a 20-year experience. , 2009, Gastrointestinal endoscopy.

[31]  Prateek Sharma,et al.  How effective is endoscopic therapy in the treatment of patients with early esophageal cancer? , 2009, Nature Clinical Practice Gastroenterology &Hepatology.